TR200202196T2 - Homolog yeniden kombine etmeyi iyileştirme yöntemleri - Google Patents

Homolog yeniden kombine etmeyi iyileştirme yöntemleri

Info

Publication number
TR200202196T2
TR200202196T2 TR2002/02196T TR200202196T TR200202196T2 TR 200202196 T2 TR200202196 T2 TR 200202196T2 TR 2002/02196 T TR2002/02196 T TR 2002/02196T TR 200202196 T TR200202196 T TR 200202196T TR 200202196 T2 TR200202196 T2 TR 200202196T2
Authority
TR
Turkey
Prior art keywords
agent
homologous recombination
methods
alteration
antibody
Prior art date
Application number
TR2002/02196T
Other languages
English (en)
Inventor
Ivanov Evguenii
Original Assignee
Transkaryotic Therapies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transkaryotic Therapies, Inc. filed Critical Transkaryotic Therapies, Inc.
Publication of TR200202196T2 publication Critical patent/TR200202196T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4712—Cystic fibrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Led Devices (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)

Abstract

Bu bulus, hedef bir DNA'nin seçilen bir bölgesinde, örn. bir hücrenin kromozomal DNA'sinda bir baskalasimi yükseltmek için bir yöntemle ilgilidir. Yöntem, bölgede (a) seçilmis DNA sekansi içeren çift sarmalli DNA sekansi; (b) homolog birlesmeyi destekleyen bir madde, örn. bir Rad52 proteini veya bunun fonksiyonel bir parçasi; ve (c) homolog olmayan uç eklenmesini inhibe eden madde örn. bir anti-Ku antikoru veya bir Ku-birlesme oligomer veya polimeri gibi bir madde saglamak ve baskalasimin gerçeklesmesini mümkün kilmaktan meydana gelir. Homolog olmayan uç eklenmesini inhibe eden madde, örn. bir anti-Ku antikoru gibi Ku'yu etkisizlestiren bir madde tercihen lokal olarak verilir. (a), (b) ve (c) maddeleri tercih edildigi gibi birlikte veya ayri ayri verilebilir.
TR2002/02196T 2000-03-14 2001-03-13 Homolog yeniden kombine etmeyi iyileştirme yöntemleri TR200202196T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/525,160 US6569681B1 (en) 2000-03-14 2000-03-14 Methods of improving homologous recombination

Publications (1)

Publication Number Publication Date
TR200202196T2 true TR200202196T2 (tr) 2003-01-21

Family

ID=24092175

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/02196T TR200202196T2 (tr) 2000-03-14 2001-03-13 Homolog yeniden kombine etmeyi iyileştirme yöntemleri

Country Status (10)

Country Link
US (1) US6569681B1 (tr)
EP (1) EP1263972B1 (tr)
JP (1) JP2003526376A (tr)
AT (1) ATE525472T1 (tr)
AU (1) AU2001245637A1 (tr)
CA (1) CA2403113A1 (tr)
DK (1) DK1263972T3 (tr)
MX (1) MXPA02009044A (tr)
TR (1) TR200202196T2 (tr)
WO (1) WO2001068882A2 (tr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL154099A0 (en) * 2000-07-27 2003-07-31 Univ Delaware A method and kit for enhancing oligonucleotide-mediated gene alteration
DK1395669T3 (da) * 2001-01-26 2009-11-16 Selexis Sa Matriks bindingsregioner og fremgangsmåder til anvendelse af disse
CA2473741C (en) * 2002-01-18 2015-12-22 Morphotek, Inc. A method for generating engineered cells for locus specific gene regulation and analysis
GB0214896D0 (en) * 2002-06-27 2002-08-07 Novartis Forschungsstiftung Gene for increased somatic recombination
FR2846337B1 (fr) 2002-10-28 2007-06-22 Centre Nat Rech Scient Procede pour inserer un acide nucleique d'interet dans une cellule procaryote ou eucaryote par recombinaison homologue
AU2003296438A1 (en) * 2002-12-24 2004-07-29 North Carolina State University Increasing gamete production with a gene switch
PL1959011T3 (pl) 2003-10-24 2012-07-31 Selexis Sa Wysokowydajny transfer genu i ekspresja w komórkach ssaczych przez procedurę wielokrotnej transfekcji sekwencji regionu przylegania do macierzy
JP4050712B2 (ja) 2004-02-27 2008-02-20 独立行政法人科学技術振興機構 相同組換えを行わせる方法
US9243043B2 (en) * 2004-04-02 2016-01-26 Dsm Ip Assets B.V. Filamentous fungal mutants with improved homologous recombination efficiency
US20060110390A1 (en) * 2004-08-25 2006-05-25 Myogen, Inc. Inhibition of Ku as a treatment for cardiovascular diseases
JP4625318B2 (ja) * 2004-12-06 2011-02-02 財団法人野田産業科学研究所 相同組換え頻度が上昇した形質転換菌
EP2045327B8 (en) 2005-03-08 2012-03-14 BASF Plant Science GmbH Expression enhancing intron sequences
EP1871868A2 (en) 2005-04-15 2008-01-02 North Carolina State University Methods and compositions to modulate adhesion and stress tolerance in bacteria
JP2007222055A (ja) * 2006-02-22 2007-09-06 Noda Inst For Scient Res 染色体領域欠失株の作製方法
JP2008263927A (ja) * 2007-04-25 2008-11-06 Noda Inst For Scient Res 染色体大領域の欠失方法
WO2008138835A1 (en) * 2007-05-09 2008-11-20 Novozymes A/S Expression cloning method suitable for selecting library clones producing a polypeptide of interest
NZ582330A (en) 2007-06-27 2012-05-25 Marinepolymer Tech Inc COMPLEXES OF IL-15 AND IL-15Ra (RECEPTOR ALPHA) AND USES THEREOF
EP2462230B1 (en) * 2009-08-03 2015-07-15 Recombinetics, Inc. Methods and compositions for targeted gene modification
AU2010282340B2 (en) 2009-08-13 2016-12-22 The Johns Hopkins University Methods of modulating immune function
WO2011078662A1 (en) * 2009-12-21 2011-06-30 Keygene N.V. Dsrna for improved genetic modification of plant dna
EP2516652B1 (en) * 2009-12-21 2014-11-05 Keygene N.V. Improved techniques for transfecting protoplasts
GB201009732D0 (en) * 2010-06-10 2010-07-21 Gene Bridges Gmbh Direct cloning
US20140304847A1 (en) * 2011-06-07 2014-10-09 Ralf Kühn Recombination efficiency by inhibition of nhej dna repair
US20150307876A1 (en) * 2012-02-10 2015-10-29 Regents Of The University Of Minnesota Dna assimilation
EP2911684B1 (en) 2012-10-24 2019-06-19 Novartis Ag Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes
WO2015066205A1 (en) * 2013-10-29 2015-05-07 Rutgers, The State University Of New Jersey Fast genetically modified organism and systems for precise genome editing and targeted genetic manipulation through enhanced homologous recombination
JP6655061B2 (ja) 2014-07-29 2020-02-26 ノバルティス アーゲー 状態を治療するためのｉｌ−１５およびｉｌ−１５ｒアルファヘテロ二量体用量増加レジメン
AU2015323966A1 (en) 2014-09-29 2017-03-16 Alexion Pharmaceuticals, Inc. Methods of treating mucopolysaccharidosis IIIB (MPSIIIB)
EP3420080B1 (en) 2016-02-22 2019-08-21 Caribou Biosciences, Inc. Methods for modulating dna repair outcomes
EP3570870A1 (en) 2017-01-20 2019-11-27 Novartis AG Combination therapy for the treatment of cancer
CA3046120A1 (en) 2017-01-20 2018-07-26 Novartis Ag Combination therapy for the treatment of cancer
JP7084021B2 (ja) * 2018-01-24 2022-06-14 公立大学法人大阪 ターゲティングベクター
CR20220367A (es) 2020-02-05 2022-08-30 Novartis Ag Célula cho que expresa heterodímeros il-15

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US6010908A (en) 1992-08-21 2000-01-04 The Regents Of The University Of California Gene therapy by small fragment homologous replacement
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
WO1993022443A1 (en) * 1992-04-24 1993-11-11 Sri International In vivo homologous sequence targeting in eukaryotic cells
US5780296A (en) 1995-01-17 1998-07-14 Thomas Jefferson University Compositions and methods to promote homologous recombination in eukaryotic cells and organisms
GB9700574D0 (en) 1997-01-13 1997-03-05 Cancer Res Campaign Tech Methods and means relating to retrotransposon and retroviral integration
ATE237136T1 (de) 1997-01-13 2003-04-15 Kudos Pharm Ltd Assay, verbindungen, therapie und nachweisverfahren um zelluläre dns-reparatur- aktivität zu modulieren
JP4062366B2 (ja) * 1997-01-17 2008-03-19 マキシジェン，インコーポレイテッド 再帰的配列組換えによる全細胞および生物の進化
US5986055A (en) 1997-11-13 1999-11-16 Curagen Corporation CDK2 interactions
DE19755952C1 (de) 1997-12-16 1998-12-10 Curt Niebling Dünnwandiges, elektro-magnetisch abschirmendes, tiefgezogenes Formteil, Verfahren zu dessen Herstellung, und ein bei diesem Verfahren einsetzbares Zwischenprodukt
US6441158B1 (en) 1997-12-31 2002-08-27 Medical College Of Georgia Research Institute, Inc. Oligomers that bind to ku protein
US6180850B1 (en) 1998-09-02 2001-01-30 Pioneer Hi-Bred International, Inc. Maize Ku70 orthologue and uses thereof
EP1093523A1 (en) 1999-05-05 2001-04-25 Pioneer Hi-Bred International, Inc. Maize rad50 orthologue and uses of therof

Also Published As

Publication number Publication date
DK1263972T3 (da) 2012-01-02
AU2001245637A1 (en) 2001-09-24
WO2001068882A2 (en) 2001-09-20
EP1263972A2 (en) 2002-12-11
EP1263972B1 (en) 2011-09-21
US6569681B1 (en) 2003-05-27
CA2403113A1 (en) 2001-09-20
WO2001068882A3 (en) 2002-03-14
MXPA02009044A (es) 2003-04-25
ATE525472T1 (de) 2011-10-15
JP2003526376A (ja) 2003-09-09

Similar Documents

Publication Publication Date Title
TR200202196T2 (tr) Homolog yeniden kombine etmeyi iyileştirme yöntemleri
CY1119263T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων
BR0210839A (pt) Sistema de recombinação, método para remover uma sequência de dna do dna cromossÈmico de uma célula ou organismo eucarióticos, organismo, cultura de célula, órgão, tecido, parte ou material de propagação transgênico, e, uso de um organismo ou de uma cultura de célula, órgão, tecido, parte ou material de propagação transgênico
DK0973928T3 (da) DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle
DE60144145D1 (de) Subtilisin-variante
WO2004022701A3 (en) Exponential amplification of nucleic acids using nicking agents
AR072695A2 (es) Proteinas insecticidas de bacillus thuringiensis
WO2004063362A3 (en) Cell cycle progression proteins
BR0112633A (pt) Método para substituir, translocar e empilhar dna em genomas eucarióticos
WO2002074237A3 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
PL1675954T3 (pl) Kwasy nukleinowe użyteczne do wywoływania śmiertelności komórek nowotworowych
WO2005044367A3 (en) Method and apparatus for cell permeabilization
WO2005025615A3 (en) FACTOR IXa SPECIFIC ANTIBODIES DISPLAYING FACTOR VIIIa LIKE ACTIVITY
WO2003076561A3 (en) Recombinase fusion protein with enhanced cellular uptake
ATE381623T1 (de) Verfahren zur expression von protein mit darin integrierter unnatürlicher aminosäure
WO2002092013A3 (en) Methods for treating liver disease and liver damage with growth hormone and foxm1b
WO2002004666A3 (en) Decondensation of dna
WO2005089426A3 (en) Method of treating sepsis
WO2003106625A3 (en) HAMMER HEAD RIBOZYMES
GB2399819A (en) Method of transducing es cells
WO2001066752A3 (en) Reproduction-specific genes
EA200301126A1 (ru) Противоопухолевая композиция, содержащая толуолсульфонамид, и способ ее применения
WO2004079332A3 (en) Composition and method for increasing efficiency of introduction of target substance into cell
WO2003030719A3 (en) Methods and kits for use in selecting approaches to treating cancer
TW200502390A (en) Sequence specific DNA recombination in eukaryotic cells